FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39274511000001108: Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64121000001115 Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64141000001113 Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has specific active ingredient Palbociclib true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Is a Palbociclib 125mg tablets 63 tablet true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has AMP Ibrance 125mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ibrance 125mg tablets (Pfizer Ltd) 63 tablet 9 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start